Evidence map›Paper›PMID 14645691›Full record

ArticleMolecular pathology : MP2003

Validation of cDNA microarray gene expression data obtained from linearly amplified RNA.

S D Jenson, R S Robetorye, S D Bohling, J A Schumacher, J W Morgan, M S Lim, K S J Elenitoba-Johnson

Abstract readValidation Study
In one paragraph

Article in Molecular pathology : MP, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Maternal peripheral blood gene expression in early pregnancy and preeclampsia.International journal of molecular epidemiology and genetics · 2011
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Global gene expression profiles reveal significant nuclear reprogramming by the blastocyst stage after cloning.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S D JensonDepartment of Pathology, University of Utah Health Sciences Centre, Salt Lake City, UT 84132, USA.
R S Robetorye
S D Bohling
J A Schumacher
J W Morgan
M S Lim
K S J Elenitoba-Johnson

Funding

RESEARCH TRAINING IN HEMATOLOGYT32DK007115 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN, PRCHAL, JOSEF T · 1986 to 2020
$8.4M
EXPRESSION PROFILING OF PROGRESSED FOLLICULAR LYMPHOMASR21CA083984 · NCI · UNIVERSITY OF UTAH · PI ELENITOBA-JOHNSON, KOJO SEYS · 2000 to 2001
$225k
NCI NIH HHS CA83984-01NIDDK NIH HHS T32 DK007115NIDDK NIH HHS T32 DK07115-24
6 · The paper itself

Abstract

backgroundDNA microarray technology has permitted the analysis of global gene expression profiles for several diseases, including cancer. However, standard hybridisation and detection protocols require micrograms of mRNA for microarray analysis, limiting broader application of this technology to small excisional biopsies, needle biopsies, and/or microdissected tissue samples. Therefore, linear amplification protocols to increase the amount of RNA have been developed. The correlation between the results of microarray experiments derived from non-amplified RNA and amplified samples needs to be evaluated in detail.

methodsTotal RNA was amplified and replicate hybridisation experiments were performed with linearly amplified (aRNA) and non-amplified mRNA from tonsillar B cells and the SUDHL-6 cell line using cDNA microarrays containing approximately 4500 genes. The results of microarray differential expression using either source of RNA (mRNA or aRNA) were also compared with those found using real time quantitative reverse transcription polymerase chain reaction (QRT-PCR).

resultsMicroarray experiments using aRNA generated reproducible data displaying only small differences to data obtained from non-amplified mRNA. The quality of the starting total RNA template and the concentration of the promoter primer used to synthesise cDNA were crucial components of the linear amplification reaction. Approximately 80% of selected upregulated and downregulated genes identified by microarray analysis using linearly amplified RNA were confirmed by QRT-PCR using non-amplified mRNA as the starting template.

conclusionsLinear RNA amplification methods can be used to generate high fidelity microarray expression data of comparable quality to data generated by microarray methods that use non-amplified mRNA samples.

Indexed as

Gene AmplificationOligonucleotide Array Sequence AnalysisHumansReverse Transcriptase Polymerase Chain ReactionRNASensitivity and SpecificityRNA

Identifiers

PMID14645691
PMCPMC1187346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.